Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
Open-market buys, last 90 days
$74,198
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$74,198. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-07-01 BAILEY DON M Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2024-02-08 BAILEY DON M Director Purchase +96,155 $1.04 $100K 158,801
2023-07-01 BAILEY DON M Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-07-01 BAILEY DON M Director Grant or award · Stock Option (right to buy) +50,000 50,000
2021-07-01 BAILEY DON M Director Grant or award · Stock Option (right to buy) +50,000 50,000
2020-07-01 BAILEY DON M Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-07-01 BAILEY DON M Director Grant or award · Stock Option (Right to Buy) −40,000 40,000
2019-03-19 BAILEY DON M Director Grant or award · Stock Option (Right to Buy) −60,000 60,000

Page 1 of 1 · 8 trades